Medical Education for Sepsis Source Control and Antibiotics
- Conditions
- Shock, SepticSepsis
- Interventions
- Behavioral: Change Management
- Registration Number
- NCT01187134
- Lead Sponsor
- Center for Sepsis Control and Care, Germany
- Brief Summary
Patients with severe sepsis or septic shock suffer from life-threatening infections. Fast and adequate therapy with antibiotics is crucial for survival. Current guidelines recommend the application of broad-spectrum antibiotics within 1 hour after diagnosis. However, recent studies showed that such treatment is delayed for several hours.
In this study, medical staff of participating hospitals is trained to achieve a duration until antimicrobial therapy of less than 1 hour. Tools of change management are used. The data are compared to a control group (hospitals without intervention).
It is hypothesized that a multifaceted educational program decreases duration until antimicrobial therapy and improves survival.
- Detailed Description
This study is a cluster randomized trial (CRT) where the hospitals are the clusters. 44 hospitals in Germany have confirmed their participation. Hospitals are randomized into two groups: a control and an interventional group. The control group receives conventional CMEs. The interventional group receives tools for increasing awareness such as posters and brochures. Quality measure such as benchmarking and feedback of quality indicators are used. Depending on the improvement process tools such as SWOT analyses and resistance radar will be implemented.
The CRT was preceded by a 5 months observational study (Dec. 2010 - April 2011). In about 1000 patients, participating hospitals documented their patients with severe sepsis or septic shock into a register. These data are used for final sample size calculation of the CRT and for stratification of the randomization.
The groups switch after completion of the CRT and observation continues. Thus, centers of the control group now receive the change management while the former intervention group is now without external support and is assessed for sustainability of the intervention. This study phase is planned for Nov. 2013 until March 2015. Sample size will be calculated when the CRT has been finished.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4138
-
For the hospitals (cluster):
- Involved in the primary care of patients with severe sepsis/septic shock
- Willing to participate in a guideline implementation process
-
For the patients:
-
New onset of suspicion of severe sepsis or septic shock in the following settings:
- Prehospital
- Emergency department
- Operating theatre
- Regular ward
- Intensive care unit (ICU)/Intermediate Care Unit (IMC)
-
-
For the hospitals (cluster):
- No intensive care unit available
- no acute care for patients with severe sepsis and septic shock
-
For the patients:
- Start of sepsis therapy in a non-study site
- Patients not admitted to the ICU/IMC
- No commitment to full medical support (i.e. DNR)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention group Change Management -
- Primary Outcome Measures
Name Time Method All-cause mortality 28 days
- Secondary Outcome Measures
Name Time Method Duration until antimicrobial therapy Duration until focus control Fraction of patients with antimicrobial therapy within 1 hour ICU and hospital mortality ICU and and hospital length of stay Frequency of blood cultures Frequency of adequate antimicrobial therapy
Trial Locations
- Locations (41)
Universitätsklinikum Ulm
🇩🇪Ulm, Germany
Universitätsklinikum Tübingen
🇩🇪Tübingen, Germany
HELIOS Klinikum Wuppertal
🇩🇪Wuppertal, Germany
Sophien- und Hufeland-Klinikum gGmbH
🇩🇪Weimar, Germany
Universitätsklinikum Carl Gustav Carus
🇩🇪Dresden, Germany
Katholisches Krankenhaus St. Johann Nepomuk
🇩🇪Erfurt, Germany
St. Georg Klinikum Eisenach gGmbH
🇩🇪Eisenach, Germany
Helios Klinikum Erfurt
🇩🇪Erfurt, Germany
Universitätklinikum Aachen
🇩🇪Aachen, Germany
Ilm-Kreis-Kliniken Arnstadt-Ilmenau GmbH
🇩🇪Ilmenau, Germany
HELIOS Klinikum Aue
🇩🇪Aue, Germany
Zentralklinik Bad Berka GmbH
🇩🇪Bad Berka, Germany
Hufelandkrankenhaus GmbH
🇩🇪Bad Langensalza, Germany
Bundeswehrkrankenhaus Berlin
🇩🇪Berlin, Germany
HELIOS Klinikum Emil von Behring
🇩🇪Berlin, Germany
Vivantes Klinikum Neukölln
🇩🇪Berlin, Germany
HELIOS St. Josefs-Hospital Bochum-Linden
🇩🇪Bochum, Germany
Ernst-Moritz-Arndt-Universität Greifswald
🇩🇪Greifswald, Germany
Universitätsklinikum Jena
🇩🇪Jena, Germany
Universitätsklinikum Kiel
🇩🇪Kiel, Germany
HELIOS-Klinikum Krefeld GmbH
🇩🇪Krefeld, Germany
Krankenhaus Landshut-Achdorf
🇩🇪Landshut, Germany
Universitätsklinikum Leipzig
🇩🇪Leipzig, Germany
Klinikum Meiningen GmbH
🇩🇪Meiningen, Germany
Saale-Unstrut-Klinikum Naumburg
🇩🇪Naumburg, Germany
Thüringen-Klinik Pößneck gGmbH
🇩🇪Pößneck, Germany
Thüringen-Kliniken "Georgius Agricola" GmbH
🇩🇪Saalfeld, Germany
ASKLEPIOS-ASB Krankenhaus Radeberg GmbH
🇩🇪Radeberg, Germany
Ev. Jung-Stilling-Krankenhaus
🇩🇪Siegen, Germany
Diakonie-Klinikum Schwäbisch-Hall gGmbH
🇩🇪Schwäbisch-Hall, Germany
HELIOS Kliniken Berlin-Buch
🇩🇪Berlin, Germany
Ev. Krankenhaus Bielefeld
🇩🇪Bielefeld, Germany
Waldkrankenhaus Rudolf Elle GmbH
🇩🇪Eisenberg, Germany
SRH Waldklinikum Gera
🇩🇪Gera, Germany
Klinik am Eichert
🇩🇪Göppingen, Germany
Bürgerhospital Friedberg
🇩🇪Friedberg, Germany
Südharz-Krankenhaus Nordhausen gGmbH
🇩🇪Nordhausen, Germany
Klinikum Oldenburg
🇩🇪Oldenburg, Germany
Klinikum Saarbrücken gGmbH
🇩🇪Saarbrücken, Germany
SRH Zentralklinikum Suhl GmbH
🇩🇪Suhl, Germany
Charité Berlin
🇩🇪Berlin, Germany